A drug discovery company targeting the regulome, the transcription factors controlling gene expression, using live-cell chemoproteomics and AI.
Talus Bioscience
Released July 30, 2026
Structure-free virtual screening model co-embedding protein residues and small molecules from sequence and 2D chemistry, scoring a compound in 10 ms.